Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ARRY [NASD]
Array BioPharma, Inc.
Index- P/E- EPS (ttm)-0.76 Insider Own16.47% Shs Outstand131.96M Perf Week-1.04%
Market Cap626.81M Forward P/E- EPS next Y-0.54 Insider Trans-2.22% Shs Float130.16M Perf Month21.17%
Income-97.20M PEG- EPS next Q-0.19 Inst Own93.40% Short Float16.28% Perf Quarter24.02%
Sales33.90M P/S18.49 EPS this Y-21.10% Inst Trans0.65% Short Ratio10.53 Perf Half Y11.76%
Book/sh-0.29 P/B- EPS next Y25.00% ROA-69.90% Target Price7.57 Perf Year0.85%
Cash/sh0.84 P/C5.66 EPS next 5Y10.00% ROE422.20% 52W Range2.98 - 5.64 Perf YTD-5.19%
Dividend- P/FCF- EPS past 5Y23.70% ROI-96.60% 52W High-15.78% Beta2.03
Dividend %- Quick Ratio2.20 Sales past 5Y11.00% Gross Margin-40.10% 52W Low59.40% ATR0.21
Employees198 Current Ratio2.20 Sales Q/Q-57.00% Oper. Margin- RSI (14)59.58 Volatility4.10% 4.85%
OptionableYes Debt/Eq- EPS Q/Q-61.50% Profit Margin- Rel Volume0.33 Prev Close4.64
ShortableYes LT Debt/Eq- EarningsFeb 02 BMO Payout- Avg Volume2.01M Price4.75
Recom1.60 SMA204.21% SMA5018.12% SMA20017.01% Volume657,044 Change2.37%
Aug-09-13Reiterated Stifel Buy $7 → $8
Jul-23-10Upgrade UBS Neutral → Buy $4.25
Apr-22-10Downgrade UBS Buy → Neutral
Nov-05-09Upgrade UBS Neutral → Buy
Sep-08-09Downgrade UBS Buy → Neutral
Sep-04-09Downgrade Robert W. Baird Outperform → Neutral $10 → $3
Sep-04-09Downgrade Leerink Swann Outperform → Mkt Perform $6 → $2
Sep-04-09Downgrade Boenning & Scattergood Outperform → Neutral
Jun-17-09Initiated Boenning & Scattergood Outperform $6
May-07-08Reiterated Rodman & Renshaw Mkt Outperform $18 → $15
Feb-07-08Initiated William Blair Outperform
Dec-20-07Reiterated Collins Stewart Buy $17 → $16
Dec-04-07Initiated Morgan Joseph Buy $16
Nov-07-07Reiterated Collins Stewart Buy $20 → $17
Oct-09-07Initiated Lehman Brothers Overweight $16
Aug-13-07Initiated Rodman & Renshaw Mkt Outperform $18
May-23-07Initiated JP Morgan Overweight
Jan-04-07Reiterated Piper Jaffray Outperform $14 → $20
Dec-12-14 05:15PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definit EDGAR Online
Dec-11-14 08:15AM  The Zacks Analyst Blog Highlights: Cubist Pharmaceuticals, bluebird bio, Amgen, Incyte and Array Zacks
Dec-05-14 08:44AM  Array BioPharma (ARRY) Shares March Higher, Can It Continue? Zacks +10.29%
07:03AM  Array BioPharma, Inc. (ARRY) in Focus: Stock Soars 14.3% Zacks
Dec-04-14 02:00PM  Array BioPharma Regains Binimetinib Rights from Novartis Zacks +14.32%
12:39PM  Mid-Day Market Update: Hawaiian Electric Climbs On Merger News; Barnes & Noble Shares Slide Benzinga
10:35AM  Array BioPharma: When Losing a Partnership Is Good News at 24/7 Wall St.
10:34AM  Story Stocks from Briefing.com Briefing.com
Dec-03-14 04:06PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definit EDGAR Online
04:01PM  Array To Regain Worldwide Rights To Binimetinib PR Newswire
04:01PM  Array Biopharma Regains Rights to Cancer Drug From Novartis at TheStreet
Nov-25-14 02:00PM  Array BioPharma To Present At The Piper Jaffray And Oppenheimer 2014 Healthcare Conferences PR Newswire
Nov-24-14 10:00AM  Array BioPharma (ARRY) Is Today's Strong On High Volume Stock at TheStreet
Nov-14-14 01:04PM  ARRAY BIOPHARMA INC Financials EDGAR Online Financials
Nov-10-14 10:00AM  Array BioPharma To Present At The Stifel 2014 Healthcare And Jefferies 2014 Global Healthcare Conferences PR Newswire
Nov-07-14 07:08PM  10-Q for Array BioPharma, Inc. Company Spotlight
Nov-05-14 04:18PM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-04-14 04:49PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Submission of Matters to a Vote o EDGAR Online
09:09AM  Array BioPharma meets 1Q profit forecasts AP
09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today CCBN
08:00AM  Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2015 PR Newswire
07:07AM  Q1 2015 Array Biopharma Inc Earnings Release - Before Market Open CCBN
Oct-29-14 01:30PM  Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2015 On November 4, 2014 PR Newswire
Oct-28-14 08:28AM  Zacks Rank #1 Additions for Tuesday Zacks +7.56%
Sep-29-14 08:05AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:00AM  Phase 2 Trial Of Binimetinib In NRAS Melanoma Shows Promising Clinical Activity PR Newswire
Sep-12-14 06:00AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Change in Directors or Princi EDGAR Online
Sep-11-14 06:12PM  Array BioPharma Appoints Victor Sandor, M.D., As Chief Medical Officer PR Newswire
Sep-03-14 04:13PM  Array BioPharma To Present At The Morgan Stanley 2014 Global Healthcare Conference PR Newswire
Aug-25-14 02:18PM  Five Billionaire-Owned Biotech Stocks You Could Acquire for 100% at TheStreet +6.42%
Aug-20-14 04:59PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
Aug-15-14 08:40AM  Array BioPharma Falls Despite Narrower-than-Expected Q4 Loss Zacks
06:00AM  ARRAY BIOPHARMA INC Files SEC form 10-K, Annual Report EDGAR Online
Aug-12-14 09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today CCBN -5.12%
07:08AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online
07:07AM  Q4 2014 Array BioPharma Inc. Earnings Release - Before Market Open CCBN
07:00AM  Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014 PR Newswire
Jul-28-14 11:00AM  Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014 On August 12, 2014 PR Newswire
Jul-24-14 07:38AM  Array BioPharma, Inc. (ARRY) Jumps: Stock Surges 10.7% Higher Zacks
Jul-23-14 02:24PM  Why Oncotheryeon, Inc., OncoMed Pharmaceuticals, Inc., and Array BioPharma Inc. Stocks Jumped Today at Motley Fool +10.69%
Jun-12-14 10:58AM  3 Reasons to Watch Array Biopharma Inc. at Motley Fool
Jun-11-14 02:00PM  Array BioPharma To Present At The Wells Fargo Securities 2014 Healthcare Conference PR Newswire
Jun-02-14 03:49PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
01:02PM  Array BioPharma receives orphan status for kinase inhibitor at theflyonthewall.com
01:00PM  Two Array-Invented MEK Inhibitors Showcased At ASCO PR Newswire
May-31-14 09:20AM  Eight Analyst Stocks to Buy Under $10 for Big Upside 24/7 Wall St.
May-30-14 08:20AM  The Zacks Analyst Blog Highlights: Facebook, AT&T, Array BioPharma, Biogen Idec and Celgene Zacks
May-29-14 04:10PM  Array BioPharma Collaborates with Biogen Zacks
May-28-14 09:14AM  Array and BioPharma Biogen to collaborate in inhibitor discovery and development at theflyonthewall.com
09:10AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
09:00AM  Array BioPharma Announces Drug Discovery Collaboration Agreement With Biogen Idec PR Newswire
May-27-14 05:30PM  Array BioPharma To Present At The Jefferies 2014 Global Healthcare Conference PR Newswire
May-20-14 12:04PM  Array BioPharma (ARRY) Presents at UBS Global Healthcare Conference (Transcript) at Seeking Alpha
May-19-14 04:07PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
03:03PM  Array BioPharma hires new Chief Scientific Officer, VP of R&D at theflyonthewall.com
03:00PM  Array BioPharma Announces Key Additions To Scientific Leadership PR Newswire
May-14-14 07:20PM  Array Biopharma's (ARRY) CEO Ron Squarer Presents at Bank of America Merrill Lynch Health Care Conference (Transcript) at Seeking Alpha
08:00AM  Array BioPharma Announces Clinical Data Presentations At The 2014 ASCO Annual Meeting PR Newswire
May-12-14 12:00PM  Array BioPharma To Present At The Bank of America Merrill Lynch Healthcare Conference and the UBS Global Healthcare Conference PR Newswire +6.60%
May-09-14 11:02AM  Array BioPharma receives orphan status for multiple myeloma treatment at theflyonthewall.com +7.95%
06:02AM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Apr-29-14 03:01PM  U.S./Canada daily earnings hits & misses April 29 - 1500 ET Reuters +7.12%
12:28PM  Array BioPharma's CEO Discusses F3Q 2014 Results - Earnings Call Transcript at Seeking Alpha
09:00AM  Array BioPharma Inc. Earnings Call scheduled for 9:00 am ET today CCBN
08:02AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online
08:00AM  Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2014 PR Newswire
07:07AM  Q3 2014 Array BioPharma Inc. Earnings Release - Before Market Open CCBN
Apr-28-14 04:01PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:00PM  Charles M. Baum, M.D., PH.D. Joins Array BioPharma Board Of Directors PR Newswire
Apr-23-14 06:30PM  Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2014 On April 29, 2014 PR Newswire
02:28PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
01:22PM  Binimetinib Continues To Advance In Clinical Development PR Newswire
Mar-27-14 02:20PM  Array BioPharma: A Biotech With Many Shots On Goal at Seeking Alpha
Mar-05-14 01:13PM  Price Movements, Clinical Trial Results, and Solid Financial Reports - Analyst Notes on Pfizer, Dendreon, DepoMed, Globus Medical, and Array PR Newswire
Mar-03-14 08:39AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:00AM  Array BioPharma Provides Clinical Update On ARRY-502 For Asthma At Scientific Meeting PR Newswire
Feb-26-14 04:26PM  [video] Array CEO: Partnerships Smart While Cancer Drug Develops at TheStreet
Feb-20-14 11:30AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Feb-18-14 12:45PM  Array BioPharma To Present At The RBC Capital Markets Global Healthcare And Cowen Annual Healthcare Conferences PR Newswire
Feb-07-14 08:15AM  Eight Biotech Stocks Trading Near $5 With Huge Upside Potential at 24/7 Wall St.
Feb-06-14 04:30PM  Array BioPharma To Present At The Leerink Swann Global Healthcare Conference PR Newswire
Feb-05-14 04:56PM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Feb-04-14 04:03PM  Array BioPharma's CEO Discusses F2Q14 Results - Earnings Call Transcript at Seeking Alpha
12:43PM  Why Array Biopharma Inc. Shares (Briefly) Popped at Motley Fool
09:00AM  Array BioPharma Inc. Earnings Call scheduled for 9:00 am ET today CCBN
08:07AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statem EDGAR Online
08:00AM  Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2014 PR Newswire
Feb-03-14 10:43AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online -6.03%
07:07AM  Q2 2014 Array BioPharma Inc. Earnings Release - After Market Close CCBN
Jan-29-14 11:00AM  Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2014 on February 4, 2014 PR Newswire -5.74%
Jan-15-14 01:09PM  Array BioPharma's CEO Presents at JPMorgan Healthcare Conference (Transcript) at Seeking Alpha
Jan-03-14 01:30PM  Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-31-13 04:18PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
Dec-27-13 04:04PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Dec-14-13 08:15AM  3 Horrendous Health-Care Stocks This Week at Motley Fool
Dec-12-13 03:16AM  Array gets a big vote of confidence optionMONSTER
Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. Its proprietary clinical programs in Phase II clinical trial include ARRY-797, a p38 program for Lamin A/C-related dilated cardiomyopathy; and ARRY-502, a CRTh2 antagonist to treat Th2-driven allergic disease. The company's proprietary programs also comprise Filanesib, a kinesin spindle protein inhibitor for multiple myeloma; and ARRY-614, a p38/Tie2 dual inhibitor for myelodysplastic syndromes. Its partnered clinical programs include various drug candidates, including Binimetinib, an MEK inhibitor for cancer; Selumetinib, an MEK inhibitor for cancer; ASLAN001/ARRY-543, an HER2/EGFR inhibitor for gastric cancer; Ipatasertib/GDC-0068, an AKT inhibitor for cancer; VTX-2337, a toll-like receptor for cancer; and Danoprevir, a Hepatitis C virus protease inhibitor. The company's partnered clinical programs also comprise LY2606368, an Chk-1 inhibitor for cancer; GDC-0575, an Chk-1 inhibitor for cancer; ARRY-380/ONT-380, an HER2 inhibitor for breast cancer,; GDC-0994, an ERK inhibitor for cancer; and LOXO-101, an PanTrk inhibitor for cancer. It has collaborations with Celgene Corporation; Celgene Alpine Investment Co., LLC; Genentech, Inc.; Loxo Oncology, Inc; Novartis International Pharmaceutical Ltd.; and Oncothyreon Inc. The company was founded in 1998 and is headquartered in Boulder, Colorado.